| Accession |
PRJCA010769 |
| Title |
An open, multicenter Phase I clinical study of safety, tolerability, pharmacokinetics, and efficacy of injectable SHR-A2009 in patients with advanced solid tumors |
| Relevance |
Medical |
| Data types |
clinical,image,Metabolic,Biomarker,Genetic data
|
| Organisms |
Homo sapiens
|
| Description |
To evaluate the safety and tolerability of SR-A2009 in patients with advanced solid tumors and provide recommended doses for subsequent clinical studies (recommended dose for phase II clinical trials, RP2D). |
| Sample scope |
Multiisolate |
| Release date |
2022-07-25 |
| Grants |
| Agency |
program |
Grant ID |
Grant title |
| Jiangsu Hengrui Pharmaceutical Co. LTD
|
|
SHR-A2009-I-101
|
|
|
|
| Submitter |
wanqiu
liang (wanqiu.liang@hengrui.com)
|
| Organization |
Jiangsu Hengrui Pharmaceutical Co. LTD |
| Submission date |
2022-07-25 |
